AZN vs COMP · P/E 28, $288.38B cap vs rev $5.63B
AstraZeneca PLC (AZN) versus Compass Inc (COMP) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Compass Inc (COMP) is a real estate services company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported COMP revenue for 2024-12-31 was $5.63B. Net income was -$154.5M. Revenue was up 15.2% from 2023-12-31 to 2024-12-31. COMP currently screens at market cap $3.35B.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. COMP currently screens at market cap $3.35B.
Not investment advice. Open the AZN and COMP stock pages for the full models.
Not investment advice.